Don't miss out on Dr. Sharol's newsletters: Get notices of herbal conferences, any book giveaways and new articles released.
The Antifungal Berberine Kills Candida
It is well known that we are having increasing issues with bacteria that are becoming resistant to antibiotics, but what is less know is that we also now have fungi becoming resistant to antifungals. Candida have increasingly become more pathogenic over the years. In this article we look at one herbal solution that has been researched more extensively than others. Before we examine how the antifungal berberine is able to reduce biofilm, growth, and kill Candida species, we need some backgrond on Candida and why berberine is studied rather than the whole herb.
Candida Species Are Becoming More Pathogenic
A variety of Candidal species are becoming more commonly pathogenic and one of the main factors causing this is the heavy use of antibiotics. The increase in antifungal drugs, and antifungal cleaners have additionally added to this dilemma, and immunosuppressive drugs have added fuel to the fire. Candida albicans remains the most common pathogenic fungi encountered in hopsitals, while the frequency of isolation of non-Candida albicans species such as C. tropicalis, C. krusei, C. glabrata and C. parapsilosis, has increased. Additionally, we now have a species of Candida that is quickly becoming immune to all antifungals. That species is Candida Auris and you can find an entire article on it here.
Researchers Searching For New Antifungals Look To Berberine As a Solution To Candida
Some Candida species are naturally resistant to antifungals, but the continuous use of antifungal drugs also leads to emergent multidrug resistant strains of Candida who were not resistant previously. This leads to the activity of researchers constantly looking for new drugs with different targets of action. The increased resistance of Candida species to various drugs has forced some researchers to start looking closer at antifungal herbal constituents such as berberine to kill Candida species.
Herbal Tidbit: Why herbal constituents? Why not whole herbs?
- Whole herbs can't be patented making them unattractive to companies that want to look for new cures, but new constituents removed from herbs and not previously used in commerce can be patented allowing the research on the constituents to be lucrative.
- Old constituents if altered chemically can also be patented.
- Single constituents are easier to study in the standard model of research that is usually undertaken in a lab.
- Standardizing some herbs in the base of the whole herb may prove to be helpful.
- There are some instances where a group of constituents are also useful, espsecially if taken out of an herb that has toxic components that are removed in the process.
Therefore constituents are usually studied due to ease of research and the abilitly to patent them and be able make money from the research. I find the USA does not have much research on whole herbs and such research is usually completed in other countries where herbs are more commonly used as medicines. In the USA companies are more interested in turning herbs into drugs rather than researching whole herbs.
One of these herbal constituents with strong antifungal activity is berberine, which has been found to kill Candida species, destroy biofilms and reduce Candida's morphing from the commensal yeast form of Candida to the more aggressive pathogenic hyphal form. Berberine is a constituent found in a number of herbs that are known for their anticandidal activity as well as their general antimicrobial activity.
Berberine is found in Goldenseal - Hydrastis canadensis, Oregon grape and other species of Berberis/ Mahonia, Phellodendron amurense, Gold thread - Coptis chinensis. Many of the antimicrobial, antifungal, antiparasitic actions of these herbs have been attributed to this one constituent. However, the whole herb is still necessary. For instance, research shows that berberine-containing Berberis species also synthesize the substances 5'-methoxyhydnocarpin-D (5'-MHC-D) and pheophorbide a, which have no antimicrobial activity, but inhibit the expression of multidrug resistant efflux pumps (MDRs) in Staphylococcus aureus and potentiate the action of berberine. The metabolites 5-methoxyhydnocarpin-D (5'-MHC) and pheophorbide a are useful for berberine to be more fully effective. Although they have no antimicrobial activity of their own, the constituent berberine is much more effective when given in conjunction with these substances or better yet, the whole plant that contains all of these substances. Studies with Candida species still need to be conducted on using whole plant, and/or using 5'-methoxyhydnocarpin-D and berberine in comparison with just berberine to see which of these scenarios will give better results.
Studies Show Antifungal Berberine Kills Candida & Decreases The Hyphal Formation Candida
Berberine Kills Planktonic Candidal Yeast Cells And Biofilm Forming Cells
In a 2016 study researchers examined the antifungal activity of berberine in fluconazole-resistant pathogenic yeasts. They specifically were looking at Candida tropicalis that was resistant to fluconazole that was being acquired in the hospital. Fluconazole is a fairly strong antifungal drug that in the past has been used to treat Candida, but now there is fluconazole-resistant candida living on hospital equipment, and various devises used in surgical procedures.
This 2016 study found that berberine not only killed the free floating candida planktonic yeast cells but also the biofilm forming cells. Since many biofilms are resistant to conventional antifungal agents this was exciting news to the researchers.
Details Of This Study
This study exposed the candida to berberine and found it caused loss of cellular membrane integrity resulting in cell membrane permeability and decreased the number of viable cells.
According to the data obtained in this study, berberine causes the death of fluconazole-resistant Candida spp. cells by apoptosis (cell suicide).
The results of this study showed that the berberine concentration necessary to inhibit both planktonic cells and preformed biofilm cells is similar. This indicates that berberine may reduce the growth of planktonic cells and inhibit the viability of cells in preformed biofilms at concentrations of 8 μg/ml and 37.5 μg/ml, respectively. This finding is relevant because biofilms are frequently associated with reduced sensitivity to conventional antifungal agents.
Hopefully, when used internally, practitioners will know enough to use berberine in conjunction with a whole plant base of Berberis spp.
Antifungal Against C. glabrata and C. albicans
Berberine has been shown to have antifungal activity against two opportunistic Candida species, C. albicans and C. glabrata, in a 2014 study where berberine treatment of Candida cells decreased the yeasts cell wall integrity via the calcineurin pathway leading to dysfunctional mitochondria and ultimately cell death. The study also assigns a new role to heat shock factor (HSF1) in combating multidrug resistance. Berberine also enhances reactive oxygen species levels.
Antifungal Berberine Inhibits Pathogenicity At Low Concentrations And At Higher Concentrations Kills Candida
This additional study shows berberines ability to kill Candida is concentration dependent, and in minimal inhibitory concentrations berberine inhibits transition of C. albicans yeast cells to the hyphal or filamentous form. Berberine was shown to affect synthesis of membrane ergosterol dose-dependently (see additional data on ergosterol below) and induced increased membrane permeability causing loss of intracellular material to the outer space (DNA/protein leakage). Berberine also caused membrane depolarization and lipid peroxidation of membrane constituents indicating its direct effect on the membrane. Reactive oxygen species levels were also increased following berberine treatment indicating further the possibility of membrane damage.
Berberine Shown to Down-regulate Candida albicans Gene Expression
In yet another study berberine is shown to down-regulate C. albicans and β-glucan synthase-related gene expressions, so as to destroy the cell wall structure of C. albicans, expose β-glucan and damage the integrity of the wall.
- Berberine's antifungal effect is dose dependent
- Minimal inhibitory doses prevent the invasive hyphal formation
- Berberine decreases β-glucan synthase-related gene expressions ultimately damaging the cell wall
- Impaired Candidal mitochondrial function
- Generation of reactive oxygen species
- Targeting cell wall iintegrity via the calcineurin pathway
- Affects heat shock transcription factor HSF1
Berberine Effective against planktonic and biofilm stages of multiple Candidal Species
In a 2020 study, berberine was found to have in vitro activity against the planktonic and biofilm stages of Candida alibicans, C. glabrata, C. krusei, and C. dubliniensis.
Anticandidal Synergy Of Berberine And Drugs
Berberine Allows Decrease of Amphotericin B by75%
Research with mice who had disseminated candidiasis from C. albicans were treated with berberine and the antifungal drug amphotericin B. Using berberine in addition to amphotericin B allowed the amphotericin B dose to be lowered by 75% showing a synergy of the drug and herbal constituent against C. albicans.
Berberine And Amphotericin B Together Increase Survival Time of Mice Significantly
Mice that were treated using a combination of amphotericin B and berberine resulted in a mean survival time of 36 d, surviving at an average of 22 d longer than the mice group treated only with the Amp B (0.5 mg/kg) who had lasted 14 days, and 20 days longer than those treated with only berberine (1mg/kg) who had lasted 17 days. Note that the berberine treated mice lasted 3 days longer than the amphotericin B treated mice.
Berberine Overcomes Antifungal resistance To Fluconazole
In vitro berberine was shown to serve as a potent Reactive Oxygen Species (ROS)-inducing agent, disrupting the antioxidant system especially in fluconazole-resistant C. albicans to overcome antifungal drug resistance.
Berberine And Amphotericin B Have A Syngergistic Effect Against biofilms of Candida and Staph aureus
In vitro synergistic effects have been shown between berberine and amphotericin B against dual-species biofilms of Candida and Staphylococcus aureus.
Berberine And Fluconazole Have A Syngergistic Effect Increasing Their Affect On C. Albicans
There was an In vitro synergistic effect between berberine hydrochloride and fluconazole that improved sensitivity of Candida albicans resistant isolates.
Berberine Works Well With Antifungals That Lower Ergosterol Levels
Fluconazole resistant C. albicans has shown tolerance to berberine also. This tolerance has been shown to disappear when fluconazole and berberine are used together. Researchers found berberine by itself increased the cellular content of ergosterol. They also found adding ergosterol to an in vitro environment increased drug efflux pump genes and decreased berberine concentration. Fluconazole and other antifungal agents which act to lower ergosterol levels were found to syngeistically work together with berberine against C. albicans while those antifungals that did not act on ergosterol were not able to act synergistically with berberine. So, it appears it is the ergosterol which is allowing C. albicans to be resistant to berberine. The antifungal drugs that lower ergosterol are the azoles and allylamines. I would like to see studies on these resistant C. albicans when whole Berberis spp. herb is used (both by itself as well as in conjunction with berberine). Whole Berbersis spp. herb also contain 5'-methoxyhydnocarpin-D (5'-MHC-D) and pheophorbide a, which have no antimicrobial activity, but inhibit the expression of multidrug resistant efflux pumps (MDRs) in Staphylococcus aureus and potentiate the action of berberine. I think these constituents are missing elements when berberine is extracted from Berberis species. By included the whole herb, or at least adding 5'methoxyhydroncarpin-D we might find the fluconazole is not needed at all or at least decreases the amount needed.
Berberine, Berberis spp. Supplements
I have mentioned that in my opinion it is best to use berberine in a base of whole Berberis/Mahonia species for antifungal activity. However, for those interested in finding berberine supplements in a base of whole Berberis such a product can be hard to find, but there are some supplements available. I am including a couple that I have used in protocols as an antifungal/antimicrobial below. (I am listing links to Amazon for these products. These are affiliate links that we receive a small commission for at no cost to you when you purchase them through these links. Additionally, you support this website by buying them through these links. You can get details on our advertising policies here.) For those searching for pure berberine products, this is much easier to find and they are usually all fairly similar.
As a reminder, remember that berberine is also found in Goldenseal - Hydrastis canadensis, Phellodendron amurense, and Gold thread - Coptis chinensis. These other herbs are used in similar manners as are the Berbersi/Mahonia species and they too probably have other constituents in them that are supportive of berberine when used for pathogens. With the issues around increasing pathogenicity of Candida it would bode well to research all of these herbs for treatment of Candida infections.
This one contains 180 Caps
This one contains 90 caps